Clinical applications of angiogenic growth factors and their inhibitors
Abstract
Promoting the formation of new collateral vessels in ischemic tissues using angiogenic growth factors (therapeutic angiogenesis) is a an exciting frontier of cardiovascular medicine. Conversely, inhibition of the action of key regulators of angiogenesis, such as VEGF, constitutes a promising approach for the treatment of solid tumors and intraocular neovascular syndromes. These concepts are being tested now in clinical trials.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In 1939, Gordon and colleagues observed in rabbit grafts that tumor growth was accompanied by rapid and extensive formation of new blood vessels.
“In 1939, Gordon and colleagues studied the relationship between tumor growth and blood supply in rabbit grafts, and they observed that tumor growth was accompanied by the rapid and extensive formation of new blood vessels.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [258]
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · see citing works
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725 · see citing works
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627 · see citing works
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727 · see citing works
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,540 · see citing works
Self-citationAbnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,114 · see citing works
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., JAMPEL, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,794 · see citing works
Self-citationHeterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,624 · see citing works
Self-citationKim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605 · see citing works
Self-citationTransplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640 · see citing works
Soker, S., Takashima, S., Miao, H., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,634 · see citing works
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · see citing works
Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J. M., & Asahara, T. (1999) · Nature Medicine · doi:10.1038/7434 · Cited by 2,421 · see citing works
Gerber, H. P., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z., & Ferrara, N. (1999) · Nature Medicine · doi:10.1038/9467 · Cited by 2,089 · see citing works
Self-citationEvidence for Circulating Bone Marrow-Derived Endothelial Cells
Shi, Q., Rafii, S., Wu, M. H.-D., Wijelath, E. S., Yu, C., Ishida, A., Fujita, Y., Kothari, S., Möhle, R., Sauvage, L. R., et al. (1998) · Blood · doi:10.1182/blood.v92.2.362 · Cited by 1,694 · see citing works
Wang, H. U., Chen, Z., & Anderson, D. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81436-1 · Cited by 1,678 · see citing works
Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., KRUMMEN, L. A., Winkler, M., & Ferrara, N. (1997) · PubMed · Cited by 1,602 · see citing works
Self-citationCarmeliet, P., Lampugnani, M. G., Moons, L., Breviario, F., Compernolle, V., Bono, F., Balconi, G., Spagnuolo, R., Oosthuyse, B., Dewerchin, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81010-7 · Cited by 1,284 · see citing works
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M. A., Fukumura, D., Jain, R. K., & Alitalo, K. K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,279 · see citing works
Self-citationBenjamin, L. E., Hemo, I., & Keshet, E. (1998) · Development · doi:10.1242/dev.125.9.1591 · Cited by 1,265 · see citing works
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L. M., Ferrara, N., King, G. L., & Smith, L. E. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,258 · see citing works
Self-citationBaumgärtner, I., Pieczek, A., Manor, O., Blair, R. H., Kearney, M., Walsh, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.12.1114 · Cited by 1,098 · see citing works
Takeshita, S., Zheng, L., Brogi, E., Kearney, M., Pu, L. L. Q., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117018 · Cited by 1,038 · see citing works
Self-citationAdams, R. H., Wilkinson, G. A., Weiss, C., Diella, F., Gale, N. W., Deutsch, U., Risau, W., & Klein, R. (1999) · Genes & Development · doi:10.1101/gad.13.3.295 · Cited by 1,024 · see citing works
Tumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996 · see citing works
Isner, J. M., Pieczek, A., Schainfeld, R. M., Blair, R. H., Haley, L. L., Asahara, T., Rosenfield, K., Razvi, S., Walsh, K., & Symes, J. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03361-2 · Cited by 990 · see citing works
Gene Therapy for Myocardial Angiogenesis
Losordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K. G., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 988 · see citing works
VEGF is required for growth and survival in neonatal mice
Gerber, H., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G.-A., Rangell, L. K., Wright, B. D., Radtke, F., Aguet, M., & Ferrara, N. (1999) · Development · doi:10.1242/dev.126.6.1149 · Cited by 913 · see citing works
Self-citationSeghezzi, G., Patel, S., Ren, C. J., Gualandris, A., Pintucci, G., Robbins, E., Shapiro, R., Galloway, A., Rifkin, D., & Mignatti, P. (1998) · Journal of Cell Biology · doi:10.1083/jcb.141.7.1659 · Cited by 887 · see citing works
Bais, C., Santomasso, B., Coso, O. A., Arvanitakis, L., Geras‐Raaka, E., Gutkind, J. S., Asch, A. S., Cesarman, E., Gerhengorn, M. C., & Mesri, E. A. (1998) · Nature · doi:10.1038/34193 · Cited by 829 · see citing works
Increased Vascularization in Mice Overexpressing Angiopoietin-1
Suri, C., McClain, J., Thurston, G., McDonald, D. M., Zhou, H., Oldmixon, E. H., Sato, T. N., & Yancopoulos, G. D. (1998) · Science · doi:10.1126/science.282.5388.468 · Cited by 818 · see citing works
Ruckman, J., Green, L. S., Beeson, J., Waugh, S. M., Gillette, W. L., Henninger, D. D., Claesson, L., & Janjić, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744 · see citing works
Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., & Jain, R. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14765 · Cited by 719 · see citing works
Self-citationAsahara, T., Chen, D., Takahashi, T., Fujikawa, K., Kearney, M., Magner, M., Yancopoulos, G. D., & Isner, J. M. (1998) · Circulation Research · doi:10.1161/01.res.83.3.233 · Cited by 683 · see citing works
Carmeliet, P., Ng, Y., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V., et al. (1999) · Nature Medicine · doi:10.1038/8379 · Cited by 679 · see citing works
Adamis, A. P. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100130062010 · Cited by 630 · see citing works
Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor‐2
Soldi, R., Mitola, S. M. F., Strasly, M., Defilippi, P., Tarone, G., & Bussolino, F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.882 · Cited by 627 · see citing works
Vascular endothelial growth factor is essential for corpus luteum angiogenesis
Ferrara, N., Chen, H., Davis-Smyth, T., Gerber, H. P., Nguyen, T.-N., Peers, D. H., Chisholm, V., Hillan, K. J., & SCHWALL, R. H. (1998) · Nature Medicine · doi:10.1038/nm0398-336 · Cited by 624 · see citing works
Self-citationAsahara, T., Bauters, C., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1995) · Circulation · doi:10.1161/01.cir.92.9.365 · Cited by 597 · see citing works
Self-citationLopez, P. F., Sippy, B., Lambert, H. M., Thach, A. B., & Hinton, D. R. (1998) · Retina · doi:10.1097/00006982-199805000-00035 · Cited by 592 · see citing works
Asahara, T., Bauters, C., Pastore, C., et al. (1995) · Circulation · doi:10.1161/01.cir.91.11.2793 · Cited by 547 · see citing works
Meyer, M., Clauss, M. A., Lepple‐Wienhues, A., Waltenberger, J. L., Augustin, H. G., Ziche, M., Lanz, C., Büttner, M., Rziha, H., & Dehio, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.2.363 · Cited by 502 · see citing works
Oh, S.-J., Jeltsch, M., Birkenhäger, R., McCarthy, J. E. G., Weich, H. A., Christ, B., Alitalo, K. K., & Wilting, J. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8639 · Cited by 496 · see citing works
Self-citationGasparini, G. M., Bonoldi, E., Gatti, C., Vinante, O., Toi, M., Tominaga, T., Gion, M., Dittadi, R., Verderio, P., Boracchi, P., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.2.139 · Cited by 492 · see citing works
Giordano, F. J., Ping, P., McKirnan, M. D., et al. (1996) · Nature Medicine · doi:10.1038/nm0596-534 · Cited by 487 · see citing works
KDR Receptor: A Key Marker Defining Hematopoietic Stem Cells
ZIEGLER, B. L., Valtieri, M., Almeida-Porada, G. D., Maria, R. D., Müller, R., Masella, B., Gabbianelli, M., Casella, I., Pelosi, E., Bock, T. A., et al. (1999) · Science · doi:10.1126/science.285.5433.1553 · Cited by 487 · see citing works
Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene
Uyttendaele, H., Marazzi, G., Wu, G., Yan, Q., Sassoon, D. A., & Kitajewski, J. (1996) · Development · doi:10.1242/dev.122.7.2251 · Cited by 485 · see citing works
Algire, G. H., Chalkley, H. W., Legallais, F. Y., & Park, H. D. (1945) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/6.1.73 · Cited by 472 · see citing works
Aliello, L. P. (1995) · Medical Entomology and Zoology · Cited by 463 · see citing works
van Bruggen, N., Thibodeaux, H., Palmer, J. T., Lee, W. P., Fu, L., Cairns, B., Tumas, D. B., Gerlai, R. T., Williams, S., Campagne, M. V. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8218 · Cited by 457 · see citing works
Self-citationBELLE, E. V., Witzenbichler, B., Chen, D., Silver, M., Chang, L., SCHWALL, R. H., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.4.381 · Cited by 446 · see citing works
Goldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8795 · Cited by 443 · see citing works
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
Millauer, B., Longhi, M. P., Plate, K. H., Shawver, L. K., Risau, W., Ullrich, A., & Strawn, L. M. (1996) · PubMed · Cited by 413 · see citing works
Ogawa, S., Oku, A., Sakaue-Sawano, A., Yamaguchi, S., Yazaki, Y., & Shibuya, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31273 · Cited by 405 · see citing works
Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization
Smith, L. E. H., Kopchick, J. J., Chen, W., Knapp, J., Kinose, F., Daley, D., Foley, E., Smith, R. G., & Schaeffer, J. M. (1997) · Science · doi:10.1126/science.276.5319.1706 · Cited by 392 · see citing works
Isner, J. M., Baumgärtner, I., Rauh, G., Schainfeld, R. M., Blair, R. H., Manor, O., Razvi, S., & Symes, J. F. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70022-9 · Cited by 387 · see citing works
Albini, A., Soldi, R., Giunciuclio, D., Giraudo, E., Benelli, R., Primo, L., Noonan, D. M., Salio, M., Camussi, G., Rock, W., et al. (1996) · Nature Medicine · doi:10.1038/nm1296-1371 · Cited by 380 · see citing works
McClure, N., Healy, D. L., Rogers, P. A. W., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)93001-5 · Cited by 375 · see citing works
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
Lin, P. C., Buxton, J. A., Acheson, A. L., Radziejewski, C. H., Maisonpierre, P. C., Yancopoulos, G. D., Channon, K. M., Hale, L. P., Dewhirst, M. W., George, S. E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8829 · Cited by 371 · see citing works
Springer, M. L., Chen, A. S., Kraft, P. E., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80154-9 · Cited by 365 · see citing works
Witzenbichler, B., Asahara, T., Murohara, T., Silver, M., Spyridopoulos, I., Magner, M., Principe, N., Kearney, M., Hu, J., & Isner, J. M. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65582-4 · Cited by 344 · see citing works
VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis
Li, J., Brown, L. F., Hibberd, M. G., Grossman, J. D., Morgan, J. P., & Simons, M. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.5.h1803 · Cited by 340 · see citing works
Borgström, P., Hillan, K. J., Sriramarao, P., & Ferrara, N. (1996) · PubMed · Cited by 331 · see citing works
Self-citationMagnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis
Pearlman, J. D., Hibberd, M. G., Chuang, M. L., et al. (1995) · Nature Medicine · doi:10.1038/nm1095-1085 · Cited by 327 · see citing works
Flk-1 as a target for tumor growth inhibition.
Strawn, L. M., McMahon, G., App, H., Schreck, R., Kuchler, W. R., Longhi, M. P., Hui, T. H., Tang, C., Levitzki, A., Gazit, A., et al. (1996) · PubMed · Cited by 317 · see citing works
Mack, C. A., Patel, S. R., Schwarz, E. A., et al. (1998) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70455-6 · Cited by 308 · see citing works
Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.
Harada, K., Grossman, W., Friedman, M., et al. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117378 · Cited by 304 · see citing works
VEGF165 mediates glomerular endothelial repair
Ostendorf, T., Kunter, U., Eitner, F., Loos, A., Regele, H. M., Kerjaschki, D., Henninger, D. D., Janjić, N., & Floege, J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6740 · Cited by 286 · see citing works
Hereditary lymphedema: evidence for linkage and genetic heterogeneity
Ferrell, R. E. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.13.2073 · Cited by 284 · see citing works
Wise, L. M., Veikkola, T., Mercer, A. A., Savory, L. J., Fleming, S. B., Caesar, C., Vitali, A. A., Mäkinen, T., Alitalo, K. K., & Stacker, S. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3071 · Cited by 272 · see citing works
Self-citationSalvén, P., Ruotsalainen, T. M., Mattson, K., & Joensuu, H. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980417)79:2 · Cited by 261 · see citing works
Lin, P., Polverini, P. J., Dewhirst, M. W., Shan, S., Rao, P. S., & Peters, K. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119740 · Cited by 252 · see citing works
Advances in Coronary Angioplasty
Bittl, J. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610243351707 · Cited by 233 · see citing works
Takeshita, S., Tsurumi, Y., Couffinahl, T., et al. (1996) · PubMed · Cited by 212 · see citing works
Greelish, J. P., Su, L. T., Lankford, E. B., Burkman, J. M., Chen, H., Koenig, S., Mercier, I. M., Desjardins, P. R., Mitchell, M. A., Zheng, X. G., et al. (1999) · Nature Medicine · doi:10.1038/7439 · Cited by 211 · see citing works
Pham, C. D., Roberts, T. P. L., van Bruggen, N., Melnyk, O. O., Mann, J. S., Ferrara, N., Cohen, R. L., & Brasch, R. C. (1998) · Cancer Investigation · doi:10.3109/07357909809039771 · Cited by 208 · see citing works
Self-citationPreclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody
Ryan, A. M., Eppler, D. B., Hagler, K. E., Bruner, R. H., Thomford, P. J., Hall, R. L., Shopp, G. M., & O’neill, C. A. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700115 · Cited by 202 · see citing works
Laitinen, M., Zachary, I. C., Breier, G., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.15-1737 · Cited by 198 · see citing works
Laitinen, M., Mäkinen, K., Manninen, H. I., Matsi, P. J., Kossila, M., Agrawal, R. S., Pakkanen, T. M., Luoma, J. S., Viita, H., Hartikainen, J. E. K., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.10-1481 · Cited by 198 · see citing works
VEGF administration in chronic myocardial ischemia in pigs
López, J. J. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00136-9 · Cited by 190 · see citing works
Shyu, K., Manor, O., Magner, M., Yancopoulos, G. D., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.19.2081 · Cited by 189 · see citing works
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00237-x · Cited by 186 · see citing works
Kong, H.-L., Hecht, D., Song, W., Kovesdi, I., Hackett, N. R., Yayon, A., & Crystal, R. G. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.6-823 · Cited by 179 · see citing works
Signaling angiogenesis and lymphangiogenesis
Korpelainen, E., & Alitalo, K. K. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80137-3 · Cited by 174 · see citing works
Self-citationSymptom reporting in cancer patients: The role of negative affect and experienced social stigma
Koller, M., Kussman, J., Lorenz, W., Jenkins, M., Voss, M., Arens, E., Richter, E., & Rothmund, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960301)77:5 · Cited by 160 · see citing works
Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb
Bauters, C., Asahara, T., Zheng, L., et al. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.4.h1263 · Cited by 154 · see citing works
Ensoli, B., Markham, P. D., Kao, V., Barillari, G., Valeria Fiorelli, A., Gendelman, R., Raffeld, M. A., Zon, G., & Gallo, R. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117521 · Cited by 135 · see citing works
Hiltunen, M., Laitinen, M., Turunen, M. P., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2262 · Cited by 135 · see citing works
Enhanced revascularization of the ischemic limb by angiogenic therapy.
Pu, L. Q., Sniderman, A. D., Brassard, R., et al. (1993) · Circulation · doi:10.1161/01.cir.88.1.208 · Cited by 133 · see citing works
Mack, C. A., Magovern, C. J., Budenbender, K. T., et al. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70236-8 · Cited by 131 · see citing works
Pathobiology of Ocular Disease
Blodi, F. C. (1983) · Archives of Ophthalmology · doi:10.1001/archopht.1983.01040010144037 · Cited by 129 · see citing works
Studies on retinal neovascularization. Friedenwald Lecture.
Pätz, A. (1980) · PubMed · Cited by 122 · see citing works
Angiogenesis and Vasculogenesis in Treatment of Cardiovascular Disease
Rivard, A., & Isner, J. M. (1998) · Molecular Medicine · doi:10.1007/bf03401749 · Cited by 60 · see citing works
Intracoronary Heparin Delivery in Humans
Camenzind, E., Kint, P.-P., Mario, C. D., et al. (1995) · Circulation · doi:10.1161/01.cir.92.9.2463 · Cited by 58 · see citing works
Henry, T. D., Rocha‐Singh, K. J., Isner, J. M., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)80928-5 · Cited by 47 · see citing works
Ylä‐Herttuala, S. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199704000-00004 · Cited by 31 · see citing works
Vascular Endothelial Growth Factor Causes Endothelial Proliferation After Vascular Injury
Burke, P., Lehmann‐Bruinsma, K., & Powell, J. S. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1194 · Cited by 29 · see citing works
Yamane, A., Mayo, M. L., Bringas, P., Chen, L., Huynh, M., Thai, K., Shum, L., & Slavkin, H. C. (1997) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199708)209:4 · Cited by 24 · see citing works
Percutaneous endoluminal treatment of aorto-abdominal occlusive diseases
Henry, M., Amor, M., Henry, I., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)80321-5 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591 · see citing works
Self-citationAngiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · see citing works
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · see citing works
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · see citing works
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653 · see citing works
Self-citationVEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691 · see citing works
Benavente-García, O., & Castillo, J. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8006568 · Cited by 1,158 · see citing works
Advances in polymeric micelles for drug delivery and tumor targeting
Kedar, U., Phutane, P., Shidhaye, S., & Kadam, V. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.05.005 · Cited by 791 · see citing works
Ouchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T., & Walsh, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310389200 · Cited by 759 · see citing works
Angiogenesis: regulators and clinical applications
Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748 · see citing works
Polymeric nanomedicine for cancer therapy
Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506 · see citing works
Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF
Cao, R., Brakenhielm, E., Wahlestedt, C., Thyberg, J., & Cao, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101564798 · Cited by 446 · see citing works
Nagata, D., Mogi, M., & Walsh, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300643200 · Cited by 331 · see citing works
The hypoxic tumour microenvironment and metastatic progression
Subarsky, P., & Hill, R. P. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022939318102 · Cited by 327 · see citing works
Yamakawa, M., Liu, L. X., Date, T., Belanger, A. J., Vincent, K. A., Akita, G. Y., Kuriyama, T., Cheng, S. H., Gregory, R. J., & Jiang, C. (2003) · Circulation Research · doi:10.1161/01.res.0000093984.48643.d7 · Cited by 327 · see citing works
Cao, R., Eriksson, A., Kubo, H., Alitalo, K., Cao, Y., & Thyberg, J. (2004) · Circulation Research · doi:10.1161/01.res.0000118600.91698.bb · Cited by 324 · see citing works
Self-citationZieris, A., Prokoph, S., Levental, K. R., Welzel, P. B., Grimmer, M., Freudenberg, U., & Werner, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.021 · Cited by 209 · see citing works
Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption
Kim, C., Yang, H., Fukushima, Y., Saw, P. E., Lee, J., Park, J.-S., Park, I., Jung, J., Kataoka, H., Lee, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.010 · Cited by 131 · see citing works
Hypoxia signaling in cancer: Implications for therapeutic interventions
Zhuang, Y., Liu, K., He, Q., Gu, X., Jiang, C., & Wu, J. (2023) · MedComm · doi:10.1002/mco2.203 · Cited by 119 · see citing works
Xu, M.-J., Song, P., Shirwany, N., Liang, B., Xing, J., Viollet, B., Wang, X., Zhu, Y., & Zou, M.-H. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.227991 · Cited by 39 · see citing works
- Authors
- Ferrara, N., & Alitalo, K.
- Affiliations
- Genentech (US)
- University of Helsinki (FI)
- Corresponding author
- Ferrara, Napoleone
- Alitalo, Kari
- Venue
- Nature Medicine
- Published
- 1999-12
- Volume
- 5
- Issue
- 12
- Pages
- 1359-1364
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1762724222
- Cited by
- 1,004
- References
- 99
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 12 · 2023: 7 · 2022: 9 · 2021: 19 · 2020: 15 · 2019: 13 · 2018: 18 · 2017: 19 · 2016: 18 · 2015: 29 · 2014: 27 · 2013: 35 · 2012: 34
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- angiogenic factors, therapeutic angiogenesis, VEGF inhibition, angiogenesis inhibitors, collateral vessel formation, ischemic tissue, solid tumors, intraocular neovascularization, clinical trials
- MeSH terms
- Animals, Coronary Disease, Growth Inhibitors, Humans, Ischemia, Lymphokines, Neoplasms, Experimental, Neovascularization, Pathologic, Recombinant Proteins, Retinal Vein, Endothelial Growth Factors, Mice, Knockout, Neovascularization, Physiologic, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review